Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
http://convention.bio.org/2018/ . The annual Woodstock/Super Bowl of Bio conventions. Four theaters with two hundred thirty nine colleagues presenting their wares. Zero listing of Mymetics in attendance nor were they part of the thirty companies who backed out.
Thank you for sharing article. I suspect April's meeting between President Trump and Mr. Gates had an impact on The House's decision to loosen FDA reigns on experimental. One can never own enough MYMX. I'd expect only a handful of shareholders exist, if Mr. Kempers ever calls a Switzerland gathering. He'd be a tough opponent at cards.
This implication should give the green light for the satellites.
https://www.washingtontimes.com/news/2018/may/24/donald-trump-orders-deregulation-boost-commercial-/
This article is old but it links back to my earlier post on the CEPI-Mymetics connection. It was authored by Mr.Trevor Mundel. He is the President of Global Health, Bill and Melinda Gates Foundation. Scroll down to the comments and you'll find a post by the honorable Ronald Kempers. This puzzle has many pieces but many irons are in the MYMX fire!
https://www.linkedin.com/pulse/cepi-innovative-new-effort-stop-pandemics-before-begin-trevor-mundel
Or...Could it be Colonel Mustard in the conservatory with the candlestick? http://www.pharmatimes.com/news/pfizer_begins_testing_rsv_vaccine_in_healthy_adults_1236543
My sentiment is very few owner's of this stock but an abundance of accumulated shares for those who do own.
Is it Schedule 13D time on nobo list?
I'd expect Round Enterprises to be active tomorrow.
Shenanigans being played with The Paul Revere call out on 5/13/17 by board posting and then a 41% unwarranted dip today. Sanofi update much needed even though it wasn't forecasted until end of the second quarter. Kempers and crew are quiet as always.
Why the carnage? 10Q? The game hasn't changed. Patience. "Management believes that the Company’s research and development activities will
result in valuable intellectual property that can generate significant revenues in the future such as by licensing."
RSV and HPIV-3 Infections Drug Development: 2018 Pipeline Review
https://www.researchandmarkets.com/research/v5fzkh/rsv_and_hpiv3?w=5
Agree with you Staypositive1. Definitely a Tide pod connoisseur who's late for his Mensa meeting.
Those $0.07's and $0.08's will return. The next floor appears to be $0.06 to $0.085. Save some dry powder if they pull the rug on us again. **I never recall the precise cause for previous Sanofi failure.** Speaking of Sanofi. Check this out: https://www.canadianmanufacturing.com/manufacturing/pharma-firm-sanofi-pasteur-to-build-500m-vaccine-manufacturing-plant-in-toronto-211466/
Agreed. They tightened up once it touched a nickel per share. It's still a bargain if one needs to accumulate. The decimal point will eventually move to the right once or twice. Timetable irrelevant. I certainly wouldn't want to be short when the news hits.
Thanks for the detailed intel. I've been watching for institutional percentage increase; even at minimal. Schwab and TDAmeritrade still have it listed at 6 percent.
I didn't see an author attached either. This current run mirrors the move from $0.028 to $0.069 in August 2017. MM's seem to be setting the foundation at mid $0.05's this week.
https://cordis.europa.eu/result/rcn/194900_en.html
It was in the first paragraph under the section with the bold heading entitled: Progress beyond the state of the art and expected potential impact (including the socio-economic impact and the wider societal implications of the project so far)
The perspective may therefore:
"-Raise high interest from major stakeholders." Absolutely shocking!
Thank you Corpus. I second that motion of "Looking Good."
What's Mymetics currently worth if Johnson and Johnson purchased Crucell for over $2.3 billion in 2016? Dr. Toon Stegmann being the common denominator of former Crucell and current Mymetics employment.
Keep your eye on the ball and or the $$$. Round Enterprises (MYMX largest current share owner) has had three recent changes in trust companies which all share the same address. Bachmann Trust Company > Ardel Trust company (Guernsey) Limited > Equiom Group.
https://www.equiomgroup.com/en/locations/europe/guernsey/
A missed opportunity for public recognition.
https://www.statnews.com/2018/04/30/bill-gates-vaccine-trump-meeting/
Could Mymetics be one of the innovative vaccine companies receiving a grant from CEPI later this year per Bill Gates Shattuck Lecture in Boston, MA today?
https://www.gatesnotes.com/Health/Shattuck-Lecture
MYMX up 95.57% since 3/23/18. https://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=MYMX
A mention of Mymetics would be healthy if mentioned on Gates Notes since he reintroduced Mosquito Week.
http://fortune.com/2018/04/18/bill-gates-foundation-malaria/
Agree. This stock being an OTC and being flat lined scares off many investors. They fail to realize that it takes time to implement the virosome studies. The true story is found once they deep dive and read the 10-K's,Q's. I expect the Sanofi 2.0 to be a success. Failure isn't an option. Once potential investors let it marinate momentum will carry this. Any PR from The Gates Foundation and consistent increase to daily volume then MYMX will fly like Lewis Hamilton exiting pit row. MYMX shares have the potential to one day be worth dollars per share. Fasten your seat belt and hold those shares tight. Risk Reward.
Correct. All lunches, date night's with the wife and attendance at offspring rugby matches should've been cancelled in September 2017 when The Apple Dumpling Gang dropped the Sanofi piggy bank. Shareholder's were booted from a low flying aircraft without a parachute two months later when the news came to light. Some investors held tight and didn't bail. He who forgets is destined to remember. However, MYMX has had ample opportunity since then to clean the air ducts, wipe down walls and sterilize those Petri dishes to get it right this time. I don't feel we would've taken on the Anergis project if the influenza virosome formulations produced weren't a success. Patience is key.
Incremental movement since 4/4/18. Potential game changer once satellites are launched and operable. Hopefully, Mr. Cantrell's coin surpasses January 2018 all time price high.
Mr. Kempers and Mr. Charlon should visit often since both Mymetics and Anergis are located in close proximity. Route de la Corniche 4 and 9A respectively , 1066 Epalinges, Switzerland.
The collaboration with Anergis appears to be another feather in the MYMX hat. Hopefully, the intellectual property will be fruitful. http://www.anergis.ch/pipeline/aller-t-birch.html